These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 23453406)

  • 1. Effect of azithromycin on anticoagulation-related outcomes in geriatric patients receiving warfarin.
    Mergenhagen KA; Olbrych PM; Mattappallil A; Krajewski MP; Ott MC
    Clin Ther; 2013 Apr; 35(4):425-30. PubMed ID: 23453406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Warfarin-antibiotic interactions in older adults of an outpatient anticoagulation clinic.
    Ghaswalla PK; Harpe SE; Tassone D; Slattum PW
    Am J Geriatr Pharmacother; 2012 Dec; 10(6):352-60. PubMed ID: 23089199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The risk of overanticoagulation with antibiotic use in outpatients on stable warfarin regimens.
    Glasheen JJ; Fugit RV; Prochazka AV
    J Gen Intern Med; 2005 Jul; 20(7):653-6. PubMed ID: 16050864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticoagulation-related outcomes in patients receiving warfarin after starting levofloxacin or gatifloxacin.
    Mathews S; Cole J; Ryono RA
    Pharmacotherapy; 2006 Oct; 26(10):1446-52. PubMed ID: 16999655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thromboembolic consequences of subtherapeutic anticoagulation in patients stabilized on warfarin therapy: the low INR study.
    Clark NP; Witt DM; Delate T; Trapp M; Garcia D; Ageno W; Hylek EM; Crowther MA;
    Pharmacotherapy; 2008 Aug; 28(8):960-7. PubMed ID: 18657012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized controlled trial of empiric warfarin dose reduction with the initiation of doxycycline therapy.
    Dowd MB; Kippes KA; Witt DM; Delate T; Martinez K
    Thromb Res; 2012 Aug; 130(2):152-6. PubMed ID: 22221937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].
    Míka P; Behounek J; Skoták M; Nevsímal L
    Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of pharmacist-managed oral anticoagulation therapy in older veterans.
    Poon IO; Lal L; Brown EN; Braun UK
    J Clin Pharm Ther; 2007 Feb; 32(1):21-9. PubMed ID: 17286786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preemptive dose reduction of warfarin in patients initiating metronidazole.
    Holt RK; Anderson EA; Cantrell MA; Shaw RF; Egge JA
    Drug Metabol Drug Interact; 2010; 25(1-4):35-9. PubMed ID: 21417792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the 5-fluorouracil-warfarin and capecitabine-warfarin drug interactions.
    Shah SR; Martin R; Dowell JE; Ussery SM
    Pharmacotherapy; 2010 Dec; 30(12):1259-65. PubMed ID: 21128758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Warfarin interactions with antibiotics in the ambulatory care setting.
    Clark NP; Delate T; Riggs CS; Witt DM; Hylek EM; Garcia DA; Ageno W; Dentali F; Crowther MA;
    JAMA Intern Med; 2014 Mar; 174(3):409-16. PubMed ID: 24445404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dietary vitamin K variability affects International Normalized Ratio (INR) coagulation indices.
    Couris R; Tataronis G; McCloskey W; Oertel L; Dallal G; Dwyer J; Blumberg JB
    Int J Vitam Nutr Res; 2006 Mar; 76(2):65-74. PubMed ID: 16941417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intensity of anticoagulation with warfarin and risk of adverse events in patients presenting to the emergency department.
    Anthony CJ; Karim S; Ackroyd-Stolarz S; Fry A; Murphy NG; Christie R; Zed PJ
    Ann Pharmacother; 2011 Jul; 45(7-8):881-7. PubMed ID: 21750309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemorrhagic events lead to an increase in international normalized ratio in patients on warfarin.
    Perona S; Ford M; Rindone J
    J Pharm Pract; 2011 Oct; 24(5):494-7. PubMed ID: 22156711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of eslicarbazepine acetate on the steady-state pharmacokinetics and pharmacodynamics of warfarin in healthy subjects during a three-stage, open-label, multiple-dose, single-period study.
    Vaz-da-Silva M; Almeida L; Falcão A; Soares E; Maia J; Nunes T; Soares-da-Silva P
    Clin Ther; 2010 Jan; 32(1):179-92. PubMed ID: 20171423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of heart failure exacerbations on anticoagulation: a prospective, observational, pilot cohort study.
    Ripley TL; Harrison D; Germany RE; Adamson PB
    Clin Ther; 2010 Mar; 32(3):506-14. PubMed ID: 20399987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of oral corticosteroids on chronic warfarin therapy.
    Hazlewood KA; Fugate SE; Harrison DL
    Ann Pharmacother; 2006 Dec; 40(12):2101-6. PubMed ID: 17119104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of oral diuretics on chronic warfarin therapy: a retrospective study.
    Edwards HD; Webb RD; Conway SE
    Expert Opin Drug Saf; 2012 May; 11(3):375-80. PubMed ID: 21957964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retrospective evaluation of a potential interaction between azithromycine and warfarin in patients stabilized on warfarin.
    Beckey NP; Parra D; Colon A
    Pharmacotherapy; 2000 Sep; 20(9):1055-9. PubMed ID: 10999497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of single-dose extended-release oral azithromycin on anticoagulation status in warfarinized patients.
    Kusafuka Y; Kurita H; Sakurai S; Suzuki S; Nakanishi Y; Katsuyama Y; Ohmori S
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2013 Feb; 115(2):148-51. PubMed ID: 23182375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.